Page last updated: 2024-09-04

abiraterone and axitinib

abiraterone has been researched along with axitinib in 1 studies

Compound Research Comparison

Studies
(abiraterone)
Trials
(abiraterone)
Recent Studies (post-2010)
(abiraterone)
Studies
(axitinib)
Trials
(axitinib)
Recent Studies (post-2010) (axitinib)
94297854765145683

Protein Interaction Comparison

ProteinTaxonomyabiraterone (IC50)axitinib (IC50)
Serine/threonine-protein kinase PLK4Homo sapiens (human)0.045
Tyrosine-protein kinase ABL1Homo sapiens (human)0.0658
Cytochrome P450 3A4Homo sapiens (human)0.046
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.0001
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.0001
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0079
Serine/threonine-protein kinase TBK1Homo sapiens (human)0.47

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goozner, M1

Other Studies

1 other study(ies) available for abiraterone and axitinib

ArticleYear
Drug approvals 2011: focus on companion diagnostics.
    Journal of the National Cancer Institute, 2012, Jan-18, Volume: 104, Issue:2

    Topics: Androstenes; Androstenols; Antibodies, Monoclonal; Antineoplastic Agents; Axitinib; Biomarkers, Tumor; Brentuximab Vedotin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Crizotinib; Drug Approval; Female; Humans; Imidazoles; Immunoconjugates; Indazoles; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Molecular Targeted Therapy; Neoplasms; Piperidines; Prostatic Neoplasms; Pyrazoles; Pyridines; Quinazolines; Rare Diseases; Sulfonamides; Survival Analysis; United States; United States Food and Drug Administration; Vemurafenib

2012